Searching map area
Lorlatinib
? TBD
Kinase inhibitor for treatment of non-small-cell lung cancer
Join to rate
Join to rate

Lorlatinib, sold under the brand name Lorbrena in the United States, Canada, and Japan, and Lorviqua in the European Union, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is an orally administered inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1), two enzymes that play a role in the...

Instance of
type of chemical entity
Subclass of
Chemical compound
Wikidata